LTB4 SWEDEN
LTB4 is developing a naturally occurring molecule stimulating the innate immunity system to target diseases such as infections and cancer.
LTB4 SWEDEN
Industry:
Biotechnology Health Care Medical Device
Founded:
2004-01-01
Address:
Gerås, Vastra Gotaland, Sweden
Country:
Sweden
Total Employee:
1+
Status:
Active
Total Funding:
0
Investors List
HealthCap
HealthCap investment in Venture Round - LTB4 Sweden
More informations about "LTB4 Sweden"
LTB4 Sweden AB - Drug pipelines, Patents, Clinical trials - Synapse
Explore LTB4 Sweden AB with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, Drug:Leukotriene B4.See details»
LTB4 Sweden - Crunchbase Company Profile & Funding
LTB4 is developing a naturally occurring molecule stimulating the innate immunity system to target diseases such as infections and cancer. Where is LTB4 Sweden's headquarters? LTB4 …See details»
LTB4 Sweden - PitchBook
Developer of small molecule intended to target diseases such as infections and cancer. The company's small molecule is made by using arachidonic acid metabolite leukotriene B4 (LTB4) …See details»
LTB4 Sweden - VentureRadar
LTB4 is a spin-out from the Karolinska Institute. The company has built its pipeline around LTB4, a naturally occurring molecule in the innate immunity system to target diseases such as …See details»
LTB4 Sweden - Funding, Financials, Valuation & Investors
Apr 23, 2015 · LTB4 is developing a naturally occurring molecule stimulating the innate immunity system to target diseases such as infections and cancer.See details»
LTB4 Sweden - Crunchbase
LTB4 is developing a naturally occurring molecule stimulating the innate immunity system to target diseases such as infections and cancer.See details»
Organization | LTB4 Sweden AB
LTB4 Sweden AB Report issue For profit Phase 2 Founded: Geras Sweden (2004)See details»
LTB4 SWEDEN AB innovation strategy - GoodIP
Get understandable and actionable insights about the innovation strategy of LTB4 SWEDEN AB. Find out in which industries it is active in and who the biggest competitors are.See details»
Leukotriene B4 - LTB4 - AdisInsight - Springer
LTB4 AB in Sweden is developing leukotriene B4 for the treatment of bronchiectasis. The company holds all rights to the naturally occurring compound for theSee details»
Leukotriene B4 - Drug Targets, Indications, Patents - Synapse
Leukotriene B4: a LTB4R agonists Drug, Initially developed by LTB4 Sweden AB, Now, its global highest R&D status is Discontinued, Mechanism: LTB4R agonists(Leukotriene B4 receptor …See details»
Recent advances in clinical development of leukotriene B4 …
Oct 1, 2017 · Drugs targeting the LTB4 pathway fall into 2 broad classes that will be discussed in this review, antagonists of the known LTB4 receptors (BLT1 and BLT2) and inhibitors of the …See details»
Leukotriene B4, an Endogenous Stimulator of the Innate Immune …
In this review, we will focus on the modulator effects of LTB 4 on the innate defenses and discuss its therapeutic potential against viral pathogens. Key Words: Leukotriene B 4, Neutrophils, Toll …See details»
Mechanisms of Leukotriene B4–Triggered Monocyte Adhesion ...
Aug 28, 2003 · Objective— Leukotriene B 4 (LTB 4) has been implicated in the trafficking of monocytes to inflammatory pathologic conditions, such as transplant rejection and …See details»
Leukotriene B4 - Wikipedia
LTB 4 is a leukotriene involved in inflammation. It is produced from leukocytes in response to inflammatory mediators and is able to induce the adhesion and activation of leukocytes on the …See details»
LTB4 Sweden - Tech Stack, Apps, Patents & Trademarks
LTB4 is developing a naturally occurring molecule stimulating the innate immunity system to target diseases such as infections and cancer.See details»
Structural basis of leukotriene B4 receptor 1 activation
Mar 3, 2022 · Leukotriene B4 receptor 1 (BLT1) plays crucial roles in the acute inflammatory responses and is a valuable target for anti-inflammation treatment, however, the mechanism …See details»
The role of the LTB4-BLT1 axis in health and disease - PubMed
Leukotriene B4 (LTB4) is a major type of lipid mediator that is rapidly generated from arachidonic acid through sequential action of 5-lipoxygenase (5-LO), 5-lipoxygenase-activating protein …See details»
The role of the LTB4-BLT1 axis in health and disease
Aug 1, 2020 · Extensive studies have demonstrated a significant role of the LTB4-BLT1 axis in the control of microbial infections, as delivery of LTB4 was beneficial, while genetic or …See details»
LTB4 Is a Signal-Relay Molecule during Neutrophil Chemotaxis
May 15, 2012 · We show that LTB 4 production dramatically amplifies formyl peptide-mediated neutrophil polarization and chemotaxis by regulating specific signaling pathways acting …See details»
A genetically encoded sensor for visualizing leukotriene B4
Aug 1, 2023 · Here, we develop GEM-LTB 4, a genetically encoded green fluorescent LTB 4 biosensor based on the human G-protein-coupled receptor BLT1. GEM-LTB 4 shows high …See details»